Neogen Corporation today announced that its rapid test for Salmonella enteritidis (SE) has received approval from the National Poultry Improvement Plan (NPIP). Neogen’s newly NPIP approved test kit, Reveal® for Salmonella enteritidis, provides commercial egg producers with a quick and easy method of detecting the dangerous pathogen, as the U.S. Food and Drug Administration (FDA) implements SE-reduction regulations.
“NPIP’s approval further validates our test as an invaluable tool to egg producers, as they comply with the FDA’s new regulations, and seek to further reduce the likelihood of SE-contaminated eggs reaching consumers,” said Ed Bradley, Neogen’s vice president of Food Safety. “Until our introduction of an effective rapid test for SE, the industry had to wait up to 7 days for an outside laboratory’s test results. Reveal for SE provides the rapid, accurate answer needed to effectively manage flocks and egg production.”
Reveal for SE is the only rapid test available for SE that follows the FDA’s sample enrichment protocol and has received NPIP approval. “Using a rapid test for SE that uses the same sample enrichment protocol as the FDA not only allows analysts to quickly screen out negative test results, but also is compatible with the FDA confirmation process by using the same enriched samples,” said Bradley.
In November, Reveal for SE received AOAC International approval, validating the accuracy of the test system when testing either environmental or pooled table egg samples. In January, the FDA determined Reveal for SE to be equivalent to the FDA’s traditional testing method in accuracy, precision, and sensitivity for detecting SE.
The objective of the National Poultry Improvement Plan is to provide a cooperative industry-state-federal program through which new technology can be effectively applied to the improvement of poultry and poultry products throughout the country. NPIP provides certification that poultry are free from disease and pathogens, such as SE.